116 related articles for article (PubMed ID: 8447306)
1. The relationship between serum calcitonin and calcium in the hemodialysis patient.
Felsenfeld AJ; Machado L; Rodriguez M
Am J Kidney Dis; 1993 Mar; 21(3):292-9. PubMed ID: 8447306
[TBL] [Abstract][Full Text] [Related]
2. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
Messa P; Mioni G; Turrin D; Guerra UP
Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
4. Sigmoidal relationship between calcitonin and calcium: studies in normal, parathyroidectomized, and azotemic rats.
Torres A; Rodriguez M; Felsenfeld A; Martin-Malo A; Llach F
Kidney Int; 1991 Oct; 40(4):700-4. PubMed ID: 1745020
[TBL] [Abstract][Full Text] [Related]
5. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.
Dunlay R; Rodriguez M; Felsenfeld AJ; Llach F
Kidney Int; 1989 Dec; 36(6):1093-8. PubMed ID: 2601258
[TBL] [Abstract][Full Text] [Related]
6. Evidence for adaptation of the entire PTH-calcium curve to sustained changes in the serum calcium in haemodialysis patients.
Borrego MJ; Felsenfeld AJ; Martin-Malo A; Almaden Y; Concepción MT; Aljama P; Rodriguez M
Nephrol Dial Transplant; 1997 Mar; 12(3):505-13. PubMed ID: 9075132
[TBL] [Abstract][Full Text] [Related]
7. Differences in the dynamics of parathyroid hormone secretion in hemodialysis patients with marked secondary hyperparathyroidism.
Felsenfeld AJ; Jara A; Pahl M; Bover J; Rodriguez M
J Am Soc Nephrol; 1995 Nov; 6(5):1371-8. PubMed ID: 8589311
[TBL] [Abstract][Full Text] [Related]
8. Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis.
Holgado R; Haire H; Ross D; Sprague S; Pahl M; Jara A; Martin-Malo A; Rodriguez M; Almaden Y; Felsenfeld AJ
J Bone Miner Res; 2000 May; 15(5):927-35. PubMed ID: 10804023
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
[TBL] [Abstract][Full Text] [Related]
10. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
11. Rate dependence of acute PTH release and association between basal plasma calcium and set point of calcium-PTH curve in dialysis patients.
De Cristofaro V; Colturi C; Masa A; Comelli M; Pedrini LA
Nephrol Dial Transplant; 2001 Jun; 16(6):1214-21. PubMed ID: 11390723
[TBL] [Abstract][Full Text] [Related]
12. Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients.
Messa P; Vallone C; Mioni G; Geatti O; Turrin D; Passoni N; Cruciatti A
Kidney Int; 1994 Dec; 46(6):1713-20. PubMed ID: 7700031
[TBL] [Abstract][Full Text] [Related]
13. Low-dose calcium versus pentagastrin for stimulation of calcitonin in chronic hemodialysis patients: a pilot study.
Thiem U; Marculescu R; Cejka D; Gessl A; Borchhardt K
J Clin Endocrinol Metab; 2014 Dec; 99(12):4704-11. PubMed ID: 25215555
[TBL] [Abstract][Full Text] [Related]
14. Effect of serum phosphate on parathyroid hormone secretion during hemodialysis.
de Francisco AL; Cobo MA; Setien MA; Rodrigo E; Fresnedo GF; Unzueta MT; Amado JA; Ruiz JC; Arias M; Rodriguez M
Kidney Int; 1998 Dec; 54(6):2140-5. PubMed ID: 9853280
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.
Santamaria R; Almaden Y; Felsenfeld A; Martin-Malo A; Gao P; Cantor T; Aljama P; Rodriguez M
Kidney Int; 2003 Nov; 64(5):1867-73. PubMed ID: 14531822
[TBL] [Abstract][Full Text] [Related]
16. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
17. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
[TBL] [Abstract][Full Text] [Related]
18. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.
Malberti F; Surian M; Cosci P
Kidney Int Suppl; 1993 Jun; 41():S125-30. PubMed ID: 8320905
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
[TBL] [Abstract][Full Text] [Related]
20. Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients.
Borrego MJ; Martin-Malo A; Almaden Y; Rodriguez M; Aljama P; Felsenfeld AJ
Am J Kidney Dis; 1999 Sep; 34(3):456-63. PubMed ID: 10469855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
